SWOG clinical trial number
CTSU/NRG-GU005
Phase III IGRT and SBRT Vs IGRT and Hypofractionated IMRT for Localized Intermediate Risk Prostate Cancer
Open
Abbreviated Title
PIII IGRT and SBRT Vs IGRT and Hypofractionated IMRT
Status Notes
This study is active in SWOG effective October 1, 2019.
Activated
10/01/2019
Research committees
Genitourinary Cancer
Treatment
Radiation Therapy
Eligibility Criteria Expand/Collapse
Please see eligibility criteria in protocol on www.CTSU.org
Other Clinical Trials
SWOG Clinical Trial Number
CTSU/NRG-GU005
Phase III IGRT and SBRT Vs IGRT and Hypofractionated IMRT for Localized Intermediate Risk Prostate Cancer
Research Committee(s)
Genitourinary Cancer
Activated
10/01/2019
Open
SWOG Clinical Trial Number
S1806
Phase III Randomized Trial of Concurrent Chemoradiotherapy with or Without Atezolizumab in Localized Muscle Invasive Bladder Cancer.
Research Committee(s)
Genitourinary Cancer
Activated
04/19/2019
Accrual
25%
Open
Phase
III
SWOG Clinical Trial Number
S1802
Phase III Randomized Trial of Standard Systemic Therapy (SST) Versus Standard Systemic Therapy plus Definitive Treatment (Surgery or Radiation) of the Primary Tumor in Metastatic Prostate Cancer
Research Committee(s)
Genitourinary Cancer
Other
Symptom Control and Quality of Life
Activated
09/17/2018
Accrual
23%
Open
Phase